Bandingkan Harga & Kinerja Jasa Marga Persero Tbk (JSMR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Jasa Marga Persero Tbk dan Brigit Biofarmaka Teknologi Tbk.: Jasa Marga Persero Tbk diperdagangkan di Rp2.950 (kapitalisasi pasar 21,7 T, volume 24 jam 1,79 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Jasa Marga Persero Tbk jauh lebih besar — sekitar 130,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Jasa Marga Persero Tbk lebih aktif diperdagangkan (1,79 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| JSMR | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 21,7 T | 166,01 M |
Volume | 1,79 jt | 324 rb |
Lot | 17,9 rb | 3,24 rb |
Perputaran | 5,26 M | 77,68 jt |
Harga Rata-rata | 2.939,86 | 239,75 |
Nilai Transaksi | 5,26 M | 77,68 jt |
Harga Ekuilibrium Indikatif | 2.950 | 240 |
Volume Ekuilibrium Indikatif | 578 | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Jasa Marga Persero Tbk
PT Jasa Marga (the Company) was established under its original name of PT Jasa Marga (Indonesia Highway Corporation) on Mar 1, 1978 then changed to PT Jasa Marga (Persero) based on Notaries Deed dated May 19, 1981 and the deed of establishment was approved by the the Ministry of Justice dated Mar 2, 1982. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Imas Fatimah, S.H., dated Apr 2, 1998, concerning UU no.1 thn 1995.
Selengkapnya di halaman JSMR →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
